Table 1.
Basic characteristics and clinical outcomes.
| Total, n = 124 | Survivor group, n = 83 | Non-survivor group, n = 41 | p value | |
|---|---|---|---|---|
| Age (years) (IQR) | 56 (38–68) | 43 (34–61) | 69 (63–78) | < 0.001 |
| Sex | ||||
| Male | 63 (50.8) | 32 (38.6) | 31 (75.6) | < 0.001 |
| Female | 61 (49.2) | 51 (61.4) | 10 (24.4) | |
| Medical history | ||||
| Hypertension | 18 (14.5) | 2 (2.4) | 16 (39.0) | < 0.001 |
| Diabetes | 5 (4.0) | 1 (1.2) | 4 (9.8) | 0.041 |
| Coronary heart disease | 8 (6.5) | 1 (1.2) | 7 (17.1) | 0.002 |
| The initial symptoms of onset | ||||
| Fever | 106 (85.5) | 73 (88.0) | 33 (80.5) | 0.267 |
| Low grade fever (37.5–38.0 °C) | 29 (23.4) | 23 (27.7) | 6 (14.6) | 0.103 |
| Moderate fever (38.1–39.0 °C) | 47 (37.9) | 34 (41.0) | 13 (31.7) | |
| High grade fever (> 39.1 °C) | 30 (24.2) | 16 (19.3) | 14 (34.1) | |
| Cough | 81 (65.3) | 54 (65.1) | 27 (65.9) | 0.930 |
| Expectoration | 43 (34.7) | 26 (31.3) | 17 (41.5) | 0.264 |
| Diarrhea | 17 (13.7) | 9 (10.8) | 8 (19.5) | 0.187 |
| Chest distress | 16 (12.9) | 4 (4.8) | 12 (29.3) | < 0.001 |
| Myalgia | 13 (10.5) | 6 (7.2) | 7 (17.1) | 0.092 |
| Severity grades | ||||
| Non-ARDS | 82 (66.1) | 82 (98.8) | 0 (0.0) | < 0.001 |
| ARDS | 42 (33.9) | 1 (1.2) | 41 (100.0) | |
| Time of admission from symptom onset (days) (IQR) | 8 (5–11) | 8 (5–11) | 9 (5–13) | 0.422 |
| Hospitalized period (days) (IQR) | 17 (11–24) | 18 (12–27) | 14 (8–22) | 0.068 |
| Period of CT follow-up from symptom onset (days) (IQR) | 32(20–46) | 39 (27–52) | 21(12–28) | 0.118 |
| Numbers of adjacent chest CT scans (days) (IQR) | 4 (2–5) | 4 (4–5) | 2 (1–2) | < 0.001 |
| Interval between adjacent chest CT scans (days) (IQR) | 6 (5–12) | 6 (5–13) | 5 (3–9) | 0.001 |